Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
CNBC Make It launches new course to help job seekers ace their interviews
© 2024 CNBC LLC. All Rights Reserved. A Division of NBCUniversal Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Market Data Terms of Use and Disclaimers Data also provided by
Options Traders pile into Delta ahead of results tomorrow
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders to discuss Delta Air Lines. 01:35 Wed, Oct 11 20236:30 PM EDT
Porsche unveils 2017 911 Turbo
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Detlev Von Platen, Porsche Cars North America talks to CNBC’s Phil LeBeau about the luxury automaker’s newest sports model. 02:17 Mon, Jan 11 20166:30 AM EST
Lightning Round: IBM is inexpensive and ‘a pretty good stock’, says Jim Cramer
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email ‘Mad Money’ host Jim Cramer weighs in on viewer stock picks including: MBIA, Whirlpool, Carnival Cruise Line, Modine Manufacturing, DraftKings and IBM. 04:49 Thu, Dec 14 20237:52 PM EST
Taiwan: the world’s new whiskey capital?
The results are in, and Taiwan’s Kavalan distillery has the best single-malt whiskey in 2015.
Suze’s top 5 ‘forever nevers’
Suze Orman counts down the five money mistakes you should never make.
